Most people who research ketamine therapy encounter IV infusions as the default — the format that most ketamine clinics offer and the one with the deepest published evidence base. At KDI Health, we offer both IV ketamine treatment infusions and intramuscular (IM) ketamine, and we believe patients deserve an honest accounting of what distinguishes these delivery methods, who each is best suited for, and what the clinical experience actually involves. Our goal is never to steer you toward one format over another for the wrong reasons; it is to match you to the approach that best fits your clinical situation.
How Intramuscular Ketamine Works
Intramuscular ketamine involves injecting ketamine directly into a large muscle — typically the deltoid or thigh — rather than delivering it through an intravenous line. Because absorption from muscle tissue is somewhat slower and less controlled than IV delivery, IM ketamine produces a bioavailability profile that differs from IV: generally equivalent in overall exposure but with a somewhat longer onset and slightly softer peak. Some patients find this gentler entry into the altered state preferable; others find they achieve better therapeutic results with the precision and controllability of IV delivery. The honest clinical picture is that both formats can be effective, and the research base for IM ketamine in psychiatric indications — while smaller than for IV — is meaningful.
Physician-First Care and Off-Label Transparency at KDI Health in Frisco, TX
At KDI Health, our approach to intramuscular ketamine treatment reflects the same physician-first philosophy that defines everything we do. Dr. Stephen Gasper — a board-certified emergency physician, former Marine, and founder of KDI Health — is personally present at every IM ketamine session, as he is at every IV infusion. We see one patient at a time. This is not standard practice across the ketamine industry, where multi-room simultaneous treatment has become common. We chose differently, deliberately. When you are in an altered dissociative state in a clinical environment, the presence of a physician who knows your history and can respond to any change in your condition matters in ways that a monitoring technician or a nurse checking in periodically cannot replicate.
Ketamine’s use for psychiatric conditions including depression, anxiety, and PTSD is off-label regardless of delivery method. The FDA approval for ketamine is limited to anesthesia use. IM ketamine specifically does not have distinct FDA approval for psychiatric applications beyond the general off-label framework that applies to all ketamine psychiatric use. We state this clearly and consistently because we believe patient trust requires transparency, not marketing language that glosses over regulatory nuance.
Who May Benefit from IM Ketamine Over IV
One practical consideration that leads some patients to explore IM over IV is access challenges with IV placement. Patients with difficult venous access — a common issue for people who have undergone repeated medical treatment, have a history of substance use affecting veins, or simply have difficult peripheral anatomy — can find IV ketamine sessions more stressful than therapeutic when the IV line is difficult to place. IM administration eliminates that barrier entirely. This is not a minor quality-of-life consideration; for patients whose anxiety spikes at the sight of a needle going into a vein, shifting to a muscle injection can meaningfully change the character of the pre-session experience.
The barrier we hear most often regarding IM ketamine specifically is confusion: patients who have researched ketamine therapy have largely read about IV and are uncertain whether IM is “the same thing” or a lesser option. Our answer is that it is neither lesser nor equivalent in a simple sense — it is a different tool with a somewhat different clinical profile, and the right choice depends on your specific situation. We walk through this decision deliberately with every patient during the consultation process, and we do not assume one is better than the other without knowing your history. For a broader look at how ketamine care has evolved, see our post on how the KDI Health team innovates ketamine care.
Cost, Insurance, and Choosing the Right Delivery Method for You
The second barrier is the same one that surrounds ketamine therapy generally: cost. Like IV ketamine, IM ketamine is typically not covered by commercial insurance for psychiatric indications. We are transparent about this from the first conversation. Results vary by individual, and we discuss realistic expectations during your consultation, drawing on both the published research and what we have observed clinically at KDI Health since our founding in 2021.
For patients interested in exploring which ketamine delivery method is right for their situation — or whether SPRAVATO® (esketamine), our FDA-approved nasal spray option, might be more appropriate — we encourage a consultation with Dr. Gasper to review your full clinical picture. These are decisions that benefit from a physician’s direct evaluation of your history, not a self-selection based on online research alone.
Frequently Asked Questions
What is IM ketamine and how is it different from IV?
Intramuscular ketamine is injected into muscle tissue rather than delivered through a vein. Absorption is slightly slower than IV, producing a somewhat different onset profile. Both formats use ketamine for off-label psychiatric purposes. The right choice depends on your clinical situation, venous access, and treatment history.
Is IM ketamine less effective than IV?
Not categorically. Both formats deliver ketamine with psychiatric benefit potential, and some patients respond well to IM who have not responded to IV, or vice versa. The IV evidence base is larger, but IM has meaningful published support. Results vary by individual.
Does Dr. Gasper personally supervise IM ketamine sessions?
Yes. Dr. Gasper personally oversees every session at KDI Health — both IV and IM — and sees one patient at a time. Direct physician oversight throughout every treatment is fundamental to our practice model.
Is IM ketamine covered by insurance?
Like IV ketamine for psychiatric indications, IM ketamine is typically not covered by commercial insurance. We discuss cost transparently at consultation.
How do I know whether IV or IM ketamine is better for me?
This is a clinical decision best made in consultation with Dr. Gasper, who will review your medical history, psychiatric history, venous access, and treatment goals. We do not apply a one-size approach.
Key Takeaways
- IM ketamine is an alternative delivery method to IV, offering equivalent total exposure with a slightly slower onset and a different peak experience profile.
- Both IV and IM ketamine are off-label for psychiatric indications; neither has specific FDA approval for depression, anxiety, or PTSD.
- KDI Health offers both formats under direct physician supervision by Dr. Gasper, who personally oversees every session.
- IM ketamine eliminates IV access barriers, which can be a meaningful advantage for patients with difficult venous anatomy or IV-related anxiety.
- Results vary by individual; a consultation with Dr. Gasper is required to determine the appropriate delivery method for your clinical situation.
Choosing a ketamine clinic is not just a treatment decision — it is a decision about who you trust with your care during a vulnerable state. At KDI Health in Frisco, TX, we built a practice around physician presence, one patient at a time, precisely because we believe that matters. If you are exploring whether IM or IV ketamine may be right for you, schedule a consultation with our team. Discuss your full history with your provider, and let Dr. Gasper help you determine which approach gives you the best chance of meaningful improvement.
About Dr. Stephen Gasper
Dr. Stephen Gasper is the owner and medical director of KDI Health Ketamine Clinic, which he founded in early 2021 in Frisco, TX. At the age of 17, he enlisted in the Marines, serving four years as a forward observer in the infantry. He then moved to Texas and obtained his BS in Biology from the University of Dallas. Dr. Gasper received his Medical Degree from UTHealth Houston in 2011 and practiced medicine in the DFW area for over 10 years as a board-certified Emergency Physician. He was inspired to found KDI Health during the COVID pandemic because of the effectiveness of ketamine as a therapy for veterans and the broader community struggling with depression, anxiety, and PTSD. Dr. Gasper personally oversees every session administered at the clinic and sees one patient at a time, providing direct physician oversight throughout each treatment.
References
American Society of Ketamine Physicians, Psychotherapists & Practitioners (ASKP3): https://www.askp3.org/
National Institute of Mental Health — Depression Treatment: https://www.nimh.nih.gov/health/topics/depression
Journal of Psychopharmacology — Intramuscular Ketamine Research: https://journals.sagepub.com/home/jop
JAMA Psychiatry — Ketamine Evidence Base: https://jamanetwork.com/journals/jamapsychiatry
U.S. Food and Drug Administration — Ketamine Prescribing Information: https://www.fda.gov/
Medical Disclaimer
The content on this page is provided by KDI Health for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Both IV and IM ketamine for psychiatric conditions represent off-label uses of an FDA-approved anesthetic. Individual results vary. This information is not a substitute for professional medical evaluation. Always discuss your health history, current medications, and treatment options with a qualified medical professional before making any decisions. If you are experiencing a mental health crisis, please call or text 988 (Suicide and Crisis Lifeline) or go to your nearest emergency room.
